Technical Analysis for EW - Edwards Lifesciences Corporation

Grade Last Price % Change Price Change
grade B 193.08 1.75% 3.32
EW closed up 1.75 percent on Thursday, July 18, 2019, on 1.15 times normal volume.

Earnings due: Jul 24

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical EW trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Cup with Handle Other 0.00%
Multiple of Ten Bullish Other 0.00%
BB Squeeze Ended Range Expansion 0.00%
Crossed Above 20 DMA Bullish 1.75%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.75%
Cup with Handle Other 1.75%
Bollinger Band Squeeze Range Contraction 1.75%
Multiple of Ten Bearish Other 1.75%
Fell Below 20 DMA Bearish 2.96%

Older signals for EW ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve; and produces pericardial and porcine valves. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery catheters and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for goal-directed fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect both patients and clinicians from the risk of infection; and products used to treat endolumenal occlusive disease, including balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.
Medicine Medical Specialties Clinical Medicine Surgery Infection Catheters Catheter Drainage Cardiac Surgery Incision Care Products Heart Repair Products Cardiac Output Edwards Lifesciences Heart Valve Valvular Heart Disease
Is EW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 197.86
52 Week Low 134.53
Average Volume 1,262,310
200-Day Moving Average 169.4837
50-Day Moving Average 182.4024
20-Day Moving Average 189.416
10-Day Moving Average 190.397
Average True Range 3.5789
ADX 25.83
+DI 30.0551
-DI 17.8255
Chandelier Exit (Long, 3 ATRs ) 184.3133
Chandelier Exit (Short, 3 ATRs ) 193.7467
Upper Bollinger Band 195.6213
Lower Bollinger Band 183.2107
Percent B (%b) 0.8
BandWidth 6.552034
MACD Line 2.187
MACD Signal Line 2.2918
MACD Histogram -0.1048
Fundamentals Value
Market Cap 40.77 Billion
Num Shares 211 Million
EPS 3.30
Price-to-Earnings (P/E) Ratio 58.51
Price-to-Sales 6.75
Price-to-Book 7.42
PEG Ratio 1.70
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 199.77
Resistance 3 (R3) 199.41 196.82 198.66
Resistance 2 (R2) 196.82 195.12 197.00 198.28
Resistance 1 (R1) 194.95 194.06 195.89 195.31 197.91
Pivot Point 192.36 192.36 192.83 192.54 192.36
Support 1 (S1) 190.49 190.66 191.43 190.85 188.25
Support 2 (S2) 187.90 189.60 188.08 187.88
Support 3 (S3) 186.03 187.90 187.51
Support 4 (S4) 186.39